{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:19:12Z","timestamp":1787030352204,"version":"build-2736575974"},"reference-count":64,"publisher":"Sociedade Brasileira de Cardiologia","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,18]]},"DOI":"10.36660\/abc.20190802","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T09:58:56Z","timestamp":1606816736000},"page":"927-935","source":"Crossref","is-referenced-by-count":22,"title":["Cardiomiopatia Hipertr\u00f3fica \u2013 Revis\u00e3o"],"prefix":"10.36660","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0607-8189","authenticated-orcid":false,"given":"Silm\u00e9ia Garcia Zanati","family":"Bazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5239-4625","authenticated-orcid":false,"given":"Gilberto Ornellas de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Ferreira da Silva Mazeto Pupo da","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabr\u00edcio Moreira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Nogueira Dias Secco","family":"Malagutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Santos Nielsen","family":"Tinasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Carlos","family":"Hueb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-8839","authenticated-orcid":false,"given":"Katashi","family":"Okoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22636","reference":[{"issue":"39","key":"key20201201095841_B1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","unstructured":"1. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35(39):2733\u20132779.","journal-title":"Eur Heart J"},{"issue":"4","key":"key20201201095841_B2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","unstructured":"2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995; 92(4):785-789.","journal-title":"Circulation"},{"issue":"4","key":"key20201201095841_B3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2362.2010.02268.x","article-title":"Hypertrophic cardiomyopathy: from genetics to treatment","volume":"40","author":"Marian","year":"2010","unstructured":"3. Marian AJ. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest. 2010; 40(4):360-369.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"key20201201095841_B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic Cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","unstructured":"4. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic Cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014; 64(1):83-99.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20201201095841_B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.repc.2017.08.005","article-title":"The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results","volume":"37","author":"Cardim","year":"2018","unstructured":"5. Cardim N, Brito D, Lopes LR, Freitas A, Ara\u00fajo C, Belo A, Gon\u00e7alves L, Mimoso J, Olivotto I, Elliott P, Madeira H. The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results. Rev Port Cardiol. 2018;37(1):1-10.","journal-title":"Rev Port Cardiol"},{"issue":"9862","key":"key20201201095841_B6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","unstructured":"6. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013; 381(9862): 242-255.","journal-title":"Lancet"},{"issue":"1","key":"key20201201095841_B7","first-page":"104","article-title":"Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics","volume":"19","author":"Alcalai","year":"2008","unstructured":"7. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. 2008; 19(1):104-110."},{"issue":"8","key":"key20201201095841_B8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","article-title":"Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives","volume":"60","author":"Maron","year":"2012","unstructured":"8. Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol. 2012;60(8):705-715.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"key20201201095841_B9","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults","volume":"358","author":"Morita","year":"2008","unstructured":"9. Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med. 2008; 358(18):1899-1908.","journal-title":"N Engl J Med"},{"issue":"9","key":"key20201201095841_B10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCULATIONAHA.109.914838","article-title":"Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies\/channelopathies in clinical practice","volume":"123","author":"Tester","year":"2011","unstructured":"10. Tester DJ, Ackerman MJ. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies\/channelopathies in clinical practice. Circulation. 2011; 123(9):1021-1037.","journal-title":"Circulation"},{"issue":"4","key":"key20201201095841_B11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/jmcc.2001.1340","article-title":"The molecular genetic basis for hypertrophic cardiomyopathy","volume":"33","author":"Marian","year":"2001","unstructured":"11. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2001; 33(4):655.","journal-title":"J Mol Cell Cardiol"},{"issue":"17","key":"key20201201095841_B12","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","unstructured":"12. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003; 107(17):2227-2232.","journal-title":"Circulation"},{"issue":"4","key":"key20201201095841_B13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007","volume":"10","author":"Richards","year":"2008","unstructured":"13. Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med. 2008; 10(4):294-300.","journal-title":"Genet Med"},{"issue":"1","key":"key20201201095841_B14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","article-title":"Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death","volume":"35","author":"Shirani","year":"2000","unstructured":"14. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000;35(1):36-44.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20201201095841_B15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","unstructured":"15. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol.1986; 8(3):545\u2013557.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20201201095841_B16","first-page":"103","article-title":"Cardiomiopatia Hipertr\u00f3fica. Conceito e Classifica\u00e7\u00e3o","volume":"66","author":"Albanesi F\u00ba FM","year":"1996","unstructured":"16. Albanesi F\u00ba FM. Cardiomiopatia Hipertr\u00f3fica. Conceito e Classifica\u00e7\u00e3o. Arq Bras Cardiol. 1996;66(2):103-105.","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"key20201201095841_B17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199703133361107","article-title":"The management of hypertrophic cardiomyopathy","volume":"336","author":"Spirito","year":"1997","unstructured":"17. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336(11):775-785.","journal-title":"N Engl J Med"},{"key":"key20201201095841_B18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of Disease Progression in Hypertophic Cardiomyopathy","volume":"5","author":"Olivotto","year":"2012","unstructured":"18. Olivotto I, Cecchi F, Poggesi C, Yacoub MH. Patterns of Disease Progression in Hypertophic Cardiomyopathy. Circ Heart Fail. 2012;5:535-546.","journal-title":"Circ Heart Fail"},{"issue":"6","key":"key20201201095841_B19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/heart.86.6.709","article-title":"Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy","volume":"86","author":"Wigle","year":"2001","unstructured":"19. Wigle ED. Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy. Heart. 2001; 86(6):709-714.","journal-title":"Heart"},{"issue":"7","key":"key20201201095841_B20","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy. Clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","unstructured":"20. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 1995;92(7):1680-1692.","journal-title":"Circulation"},{"issue":"7","key":"key20201201095841_B21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","unstructured":"21. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999;281(7):650-655.","journal-title":"JAMA"},{"issue":"10","key":"key20201201095841_B22","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","unstructured":"22. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287(10):1308-1320.","journal-title":"JAMA"},{"issue":"21","key":"key20201201095841_B23","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","unstructured":"23. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006; 114(21):2232-2239.","journal-title":"Circulation"},{"issue":"4","key":"key20201201095841_B24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","unstructured":"24. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348(4):295-303.","journal-title":"N Engl J Med"},{"issue":"10","key":"key20201201095841_B25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9149(99)80198-2","article-title":"The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy","volume":"76","author":"Ryan","year":"1995","unstructured":"25. Ryan MP, Cleland JG, French JA, Joshi J, Choudhury L, Chojnowska L, Michalak E, al-Mahdawi S, Nihoyannopoulos P, Oakley CM. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol. 1995;76(10):689-694.","journal-title":"Am J Cardiol"},{"issue":"3","key":"key20201201095841_B26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jacc.2009.02.071","article-title":"Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram","volume":"54","author":"McLeod","year":"2009","unstructured":"26. McLeod CJ, Ackerman MJ, Nishimura RA, Tajik AJ, Gersh BJ, Ommen SR. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol. 2009; 54(3):229-233.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"key20201201095841_B27","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Gersh","year":"2011","unstructured":"27. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF\/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011; 58(25):e212-e260.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20201201095841_B28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiol.14131626","article-title":"MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside","volume":"273","author":"Bogaert","year":"2014","unstructured":"28. Bogaert J, Olivotto I. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside. Radiology. 2014; 273(2):329-348.","journal-title":"Radiology"},{"issue":"3","key":"key20201201095841_B29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","article-title":"Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association","volume":"16","author":"Cardim","year":"2015","unstructured":"29. Cardim N, Galderisi M, Edvardsen T, Plein S, Popescu BA, D'Andrea A, Bruder O, Cosyns B, Davin L, Donal E, Freitas A, Habib G, Kitsiou A, Petersen SE, Schroeder S, Lancellotti P, Camici P, Dulgheru R, Hagendorff A, Lombardi M, Muraru D, Sicari R. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging. 2015;16(3):280-314.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"key20201201095841_B30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.echo.2011.03.006","article-title":"American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography","volume":"24","author":"Nagueh","year":"2011","unstructured":"30. Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B, Goldstein SA, Hung J, Maron MS, Ommen SR, Woo A. American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J AM Soc Echocardiogr. 2011;24(5):473-498.","journal-title":"J AM Soc Echocardiogr"},{"issue":"47","key":"key20201201095841_B31","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1093\/eurheartj\/eht433","article-title":"Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription","volume":"34","author":"Budts","year":"2013","unstructured":"31. Budts W, B\u00f6rjesson M, Chessa M, van Buuren F, Trigo Trindade P, Corrado D, Heidbuchel H, Webb G, Holm J, Papadakis M. Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription. Eur Heart J. 2013; 34(47):3669-3674.","journal-title":"Eur Heart J"},{"issue":"21","key":"key20201201095841_B32","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1161\/CIR.0b013e318293688f","article-title":"Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association","volume":"127","author":"Longmuir","year":"2013","unstructured":"32. Longmuir PE, Brothers JA, de Ferranti SD, Hayman LL, Van Hare GF, Matherne GP, Davis CK, Joy EA, McCrindle BW. Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013; 127(21):2147-2159.","journal-title":"Circulation"},{"issue":"8","key":"key20201201095841_B33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","unstructured":"33. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005; 45(8):1251-1258.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"key20201201095841_B34","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","unstructured":"34. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001; 104(21):2517-2524.","journal-title":"Circulation"},{"issue":"6","key":"key20201201095841_B35","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","article-title":"Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population","volume":"26","author":"Cecchi","year":"1995","unstructured":"35. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 1995;26(6):1529-1536.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"key20201201095841_B36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1253\/jcj.61.673","article-title":"Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation","volume":"61","author":"Higashikawa","year":"1997","unstructured":"36. Higashikawa M, Nakamura Y, Yoshida M, Kinoshita M. Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. Jpn Circ J. 1997;61(8):673-681.","journal-title":"Jpn Circ J"},{"issue":"7","key":"key20201201095841_B37","first-page":"e257","article-title":"ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)","volume":"114","author":"Fuster","year":"2006","unstructured":"37. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation. 2006; 114(7):e257-e354.","journal-title":"Circulation"},{"issue":"5","key":"key20201201095841_B38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and prognostic significance of arrhythmias on ambulatory. Holter electrocardiogram in hypertrophic cardiomyopathy","volume":"45","author":"Adabag","year":"2005","unstructured":"38. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory. Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005; 45(5):697-704.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20201201095841_B39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","unstructured":"39. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol. 2003; 42(5):873-879.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20201201095841_B40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/hrt.79.4.331","article-title":"Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population","volume":"79","author":"Cecchi","year":"1998","unstructured":"40. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart. 1998;79(4):331-336.","journal-title":"Heart"},{"issue":"7","key":"key20201201095841_B41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0002-9149(84)80212-X","article-title":"Amiodarone for long-term management of patients with hypertrophic cardiomyopathy","volume":"54","author":"McKenna","year":"1984","unstructured":"41. McKenna WJ, Harris L, Rowland E, Kleinebenne A, Krikler DM, Oakley CM, Goodwin JF. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol. 1984;54(7):802-810.","journal-title":"Am J Cardiol"},{"issue":"21","key":"key20201201095841_B42","first-page":"e350","article-title":"ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons","volume":"117","author":"Epstein","year":"2008","unstructured":"42. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008; 117(21):e350-408.","journal-title":"Circulation"},{"issue":"7552","key":"key20201201095841_B43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bmj.332.7552.1251","article-title":"Management of hypertrophic cardiomyopathy","volume":"332","author":"Spirito","year":"2006","unstructured":"43. Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ. 2006; 332(7552):1251-1255.","journal-title":"BMJ"},{"issue":"3","key":"key20201201095841_B44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/heartjnl-2012-301996","article-title":"Prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"100","author":"O'Mahony","year":"2014","unstructured":"44. O'Mahony C, Elliot PM. Prevention of sudden cardiac death in hypertrophic cardiomyopathy. Heart. 2014;100(3):254-260.","journal-title":"Heart"},{"issue":"3","key":"key20201201095841_B45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0002-9149(81)90535-X","article-title":"Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features","volume":"47","author":"McKenna","year":"1981","unstructured":"45. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47(3):532-538.","journal-title":"Am J Cardiol"},{"issue":"16","key":"key20201201095841_B46","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/euhj.2001.2824","article-title":"Task Force on Sudden Cardiac Death of the European Society of Cardiology","volume":"22","author":"Priori","year":"2001","unstructured":"46. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001; 22(16):1374-1450.","journal-title":"Eur Heart J"},{"issue":"9","key":"key20201201095841_B47","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy","volume":"96","author":"Sadoul","year":"1997","unstructured":"47. Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation. 1997; 96(9):2987-2991.","journal-title":"Circulation"},{"issue":"24","key":"key20201201095841_B48","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","unstructured":"48. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342(24):1778-1785.","journal-title":"N Engl J Med"},{"issue":"7","key":"key20201201095841_B49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy","volume":"4","author":"Maron","year":"2019","unstructured":"49. Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, Koethe BC, Romashko M, Link MS, Maron BJ. Enhanced American College of Cardiology\/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019;4(7):644-657.","journal-title":"JAMA Cardiol"},{"issue":"6","key":"key20201201095841_B50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","unstructured":"50. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000; 342(6):365-373.","journal-title":"N Engl J Med"},{"issue":"4","key":"key20201201095841_B51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","unstructured":"51. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007; 298(4):405-412.","journal-title":"JAMA"},{"issue":"30","key":"key20201201095841_B52","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","unstructured":"52. O'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J. 2014; 35(30): 2010-2020.","journal-title":"Eur Heart J"},{"issue":"1","key":"key20201201095841_B53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-5223(05)80026-1","article-title":"Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results","volume":"110","author":"Heric","year":"1995","unstructured":"53. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results. J Thorac Cardiovasc Surg. 1995;110(1):195-206.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"key20201201095841_B54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.athoracsur.2007.07.063","article-title":"Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"85","author":"Smedira","year":"2008","unstructured":"54. Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, Dolney DO, Blackstone EH. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 2008; 85(1):127-133.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"key20201201095841_B55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","unstructured":"55. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005; 46(3):470-476.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"key20201201095841_B56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1540-8183.2006.00153.x","article-title":"Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies","volume":"19","author":"Alam","year":"2006","unstructured":"56. Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol. 2006;19(4):319-327.","journal-title":"J Interv Cardiol"},{"issue":"20","key":"key20201201095841_B57","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","unstructured":"57. Sorajja P, Ommen SR, Holmes DR Jr, Dearani JA, Rihal CS, Gersh BJ, Lennon RJ, Nishimura RA. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 2012; 126(20):2374-2380.","journal-title":"Circulation"},{"issue":"9","key":"key20201201095841_B58","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/eurheartj\/ehp016","article-title":"Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis","volume":"30","author":"Alam","year":"2009","unstructured":"58. Alam M, Dokainish H, Lakkis NM. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J. 2009;30(9):1080-1087.","journal-title":"Eur Heart J"},{"issue":"21","key":"key20201201095841_B59","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","unstructured":"59. McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J. 2007;28(21):2583-2588.","journal-title":"Eur Heart J"},{"issue":"22","key":"key20201201095841_B60","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","unstructured":"60. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999;99(22):2927-2933.","journal-title":"Circulation"},{"issue":"4","key":"key20201201095841_B61","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.amjcard.2010.10.022","article-title":"Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy","volume":"107","author":"Maron","year":"2011","unstructured":"61. Maron BJ, Yeates L, Semsarian C. Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy. Am J Cardiol. 2011; 107(4):604-608.","journal-title":"Am J Cardiol"},{"issue":"11","key":"key20201201095841_B62","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jacc.2004.08.052","article-title":"Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy","volume":"44","author":"Maron","year":"2004","unstructured":"62. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 44(11):2125-2132.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20201201095841_B63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","article-title":"Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy","volume":"104","author":"Nagueh","year":"2001","unstructured":"63. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Qui\u00f1ones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001; 104(2):128-130.","journal-title":"Circulation"},{"issue":"16","key":"key20201201095841_B64","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.99.16.2132","article-title":"Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis","volume":"99","author":"Spirito","year":"1999","unstructured":"64. Spirito P, Rapezzi C, Bellone P, Betocchi S, Autore C, Conte MR, Bezante GP, Bruzzi P. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation. 1999;99(16):2132-2137.","journal-title":"Circulation"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/abccardiol.org\/article\/cardiomiopatia-hipertrofica-revisao\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T09:02:32Z","timestamp":1747386152000},"score":1,"resource":{"primary":{"URL":"http:\/\/abccardiol.org\/article\/cardiomiopatia-hipertrofica-revisao\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11,18]]}},"alternative-id":["10.36660\/abc.20190802"],"URL":"https:\/\/doi.org\/10.36660\/abc.20190802","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}